Boulder Creek, CA, United States of America

Beth Nelson

USPTO Granted Patents = 2 


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovator Behind Glucoamylase Variants: Beth Nelson

Introduction

Beth Nelson is a distinguished inventor based in Boulder Creek, CA, renowned for her contributions to the field of biotechnology. With a total of two patents under her name, she has made significant advancements in the development of glucoamylase variants, which have important applications in starch conversion processes.

Latest Patents

Beth's latest patents are focused on the innovation of glucoamylase variants and the polynucleotides encoding these variants. The first patent pertains to the unique characteristics of glucoamylase variants, which include methods of producing these variants and their applications in producing fermentation products, such as ethanol, as well as glucose syrups. The second patent emphasizes the enhancement in specific activity and melting temperature of these variants, showcasing their potential in various biotechnological applications. The glucoamylase variants described in her patents exhibit impressive sequence identity to established amino acid sequences, marking a significant leap in the field.

Career Highlights

Beth Nelson is currently employed at Novozymes A/S, a leading company in the biotechnology sector that specializes in enzyme production. Her dedication and expertise in the field have allowed her to contribute to impactful innovations that address industry needs. With her background in biotechnology, she continues to explore advancements that propel the industry forward.

Collaborations

Throughout her career, Beth has had the opportunity to collaborate with talented coworkers, including Shikha Gupta and Allan Svendsen. These partnerships enhance her research efforts and extend the reach of her innovative solutions, fostering an environment of shared knowledge and creativity within her team.

Conclusion

Beth Nelson's work in the development of glucoamylase variants exemplifies her commitment to innovation in biotechnology. Her patents not only demonstrate her inventive prowess but also offer solutions that contribute substantially to the production of essential fermentation products. As she continues her work at Novozymes A/S, her contributions are sure to leave a lasting impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…